Amgen reports Repatha (evolocumab) cuts risk of first major CV events by 31% in high-risk patients without known significant atherosclerosis

GE HealthCare's Photonova Spectra gains FDA clearance

IsomAb names new CEO

Nuwellis completes Rendiatech acquisition

HeartBeam and Mount Sinai partner to advance AI-enabled cardiac monitoring

Medicomp Systems client IJN in Malaysia granted Stage 7 validation from HIMSS EMRAM

Precision BioSciences receives FDA Fast Track designation for PBGENE-DMD

GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care

Esperion to acquire Corstasis, expanding cardiovascular portfolio

Circio reports up to 50-fold gene expression gain in eye for circVec-AAV platform

Celyad Oncology sells C-Cathez catheter to CellProthera

Realheart secures European patent for artificial heart technology

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Boehringer Ingelheim's VETMEDIN gains US FDA approval to delay congestive heart failure onset in dogs

Myqorzo and Redemplo receive regulatory approval in China